Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$506M |
| 2 |
Microsoft
MSFT
|
+$355M |
| 3 |
ExxonMobil
XOM
|
+$267M |
| 4 |
Amazon
AMZN
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$86.2M |
| 2 |
Suncor Energy
SU
|
+$80.1M |
| 3 |
SE
Spectra Energy Corp Wi
SE
|
+$79.6M |
| 4 |
STJ
St Jude Medical
STJ
|
+$63.5M |
| 5 |
TC Energy
TRP
|
+$59.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Healthcare | 15% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.48% |
| 5 | Industrials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
376
DELISTED
Hologic
HOLX
| $43.7M | 0.05% |
1,028,124
+195,100
| +23% | +$7.95M |
|
377
Trip.com Group
TCOM
$29.1B
| $43.7M | 0.05% |
889,662
+148,266
| +20% | +$6.79M |
|
378
Ball Corp
BALL
$16.8B
| $43.7M | 0.05% |
1,177,142
+242,800
| +26% | +$9.06M |
|
379
Centene
CNC
$32.5B
| $43.2M | 0.05% |
1,211,128
+268,800
| +29% | +$9M |
|
380
Universal Health Services
UHS
$10.5B
| $43.1M | 0.05% |
346,300
+69,800
| +25% | +$8.25M |
|
381
Cenovus Energy
CVE
$52.1B
| $42.9M | 0.05% |
3,794,200
-854,200
| -18% | -$11.5M |
|
382
CGI
GIB
$15.5B
| $42.2M | 0.05% |
881,500
-328,400
| -27% | -$15.8M |
|
383
IQVIA
IQV
$39.3B
| $42.2M | 0.05% |
523,419
+112,200
| +27% | +$8.76M |
|
384
Albemarle
ALB
$15.5B
| $42.1M | 0.05% |
398,606
+87,900
| +28% | +$8.55M |
|
|
TIF
385
DELISTED
Tiffany & Co.
TIF
| $42M | 0.05% |
440,948
+90,900
| +26% | +$7.76M |
|
386
Eastman Chemical
EMN
$8.42B
| $42M | 0.05% |
520,038
+109,200
| +27% | +$8.59M |
|
387
D.R. Horton
DHI
$42.3B
| $41.8M | 0.05% |
1,255,274
+281,200
| +29% | +$8.72M |
|
|
WP
388
DELISTED
Worldpay, Inc.
WP
| $41.8M | 0.05% |
651,200
+143,700
| +28% | +$9.14M |
|
389
TransDigm Group
TDG
$67.7B
| $41.6M | 0.05% |
189,000
+40,700
| +27% | +$9.71M |
|
390
ResMed
RMD
$30.7B
| $41.4M | 0.05% |
575,300
+113,900
| +25% | +$7.87M |
|
391
Oneok
OKE
$54.5B
| $41.4M | 0.05% |
745,912
+164,700
| +28% | +$9.06M |
|
392
NetApp
NTAP
$37.2B
| $41.3M | 0.05% |
987,238
+208,200
| +27% | +$8.21M |
|
393
International Flavors & Fragrances
IFF
$21.9B
| $41.2M | 0.05% |
310,864
+61,500
| +25% | +$7.55M |
|
394
Tapestry
TPR
$32.8B
| $41.1M | 0.05% |
993,373
+224,400
| +29% | +$8.46M |
|
395
Hilton Worldwide
HLT
$71.5B
| $41M | 0.05% |
701,366
+149,999
| +27% | +$8.71M |
|
396
Mid-America Apartment Communities
MAA
$15.7B
| $40.9M | 0.05% |
402,376
+92,400
| +30% | +$9.13M |
|
397
Howmet Aerospace
HWM
$112B
| $40.9M | 0.05% |
2,026,018
+444,664
| +28% | +$8.74M |
|
398
Advanced Micro Devices
AMD
$789B
| $40.6M | 0.05% |
2,792,400
+1,545,547
| +124% | +$19.6M |
|
399
Bath & Body Works
BBWI
$4.1B
| $40.6M | 0.05% |
1,065,291
+223,279
| +27% | +$10.1M |
|
400
Brown-Forman Class B
BF.B
$13.1B
| $40.5M | 0.05% |
1,368,688
+252,032
| +23% | +$7.5M |
|
Similar funds
Swiss National Bank's Q1 2017 Portfolio in Review
As of Q1 2017, Swiss National Bank held 2,570 positions worth $80.4B, up 27% from $63.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Swiss National Bank deployed $13.1B of net new capital in Q1 2017, opening 6 new positions and adding to 1,330 existing holdings. Its largest new stake was Qiagen: 988,583 shares worth $30.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Canadian National Railway, an estimated $86.2M trimmed.
- Swiss National Bank's largest Q1 2017 buy was Qiagen: 988,583 shares worth $30.5M.
- Swiss National Bank added most to Apple in Q1 2017, an estimated $506M increase.
- Swiss National Bank's biggest Q1 2017 reduction was Canadian National Railway, cutting an estimated $86.2M.
- Swiss National Bank fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $79.6M.
- Swiss National Bank's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2017.
- Swiss National Bank opened 6 new positions and closed 36 in Q1 2017.
- Swiss National Bank's portfolio value rose 27% quarter-over-quarter to $80.4B.
Based on Swiss National Bank's 13F filing for Q1 2017, filed 4 May 2017.